"The racial and ethnic distribution of United States sperm donors differs significantly from the United States population, particularly for those of African American or Black descent,” Cassie Hobbs, MD, explained.
In an oral abstract presentation at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo in New Orleans, Louisiana, Cassie Hobbs, MD, of Women and Infants Hospital, Warren Alpert Medical School of Brown University, presented data on the racial and ethnic distribution of US sperm donor banks.
Hobbs explained that people who identify as racial or ethnic minorities often describe having a difficult time finding sperm donors that are concordant with their race, motivating the study.
The specific objective of the investigation was to determine whether the racial and ethnic distribution of US sperm donors differs from the demographics of the US male population and donor sperm recipients undergoing treatment with in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
The data demonstrated a significant difference in the racial and ethnic distribution of sperm donors from the target demographic, prompting questions about acceptance rates of Black sperm donors compared with acceptance rates of White and Asian donors.
Data from 18 sperm banks comprising 1500 sperm donors with recorded racial information were analyzed over a two-year period. Additionally, information on individuals using donor sperm for IVF or ICSI was collected, and data on the adult male population was sourced from the US Census.
The findings revealed significant disparities in the racial and ethnic distribution of sperm donors compared with the general US population. Asian sperm donors were overrepresented, constituting 18% of the sample, compared with 5% of Asian males in the US population.
The representation of White donors (61%) closely mirrored the percentage of White males in the general US population (63%). However, there was a striking underrepresentation of Hispanic sperm donors, constituting just 5%, compared with the 70% of Hispanics in the broader population.
Additionally, the presence of Black individuals among sperm donors was notably low, falling below 3%, in contrast to their 11% representation in the broader US population.
Despite the low representation of Black individuals among sperm donors, there was a higher demand for Black donor sperm, with 13% of individuals using donor sperm for IVF or ICSI being Black. Hobbs noted this discrepancy highlights a concerning trend where the supply of racially diverse sperm does not meet the demand, particularly for African American or Black individuals.
“So, that's how we came up with our ultimate conclusion that the racial and ethnic distribution of United States sperm donors differs significantly from the United States population, particularly for those of African American or Black descent,” Hobbs said in the presentation. “So really, we need either targeted recruitment or some type of education so that we can decrease this disparity and really make third-party reproduction accessible and equitable for all.”
The investigators recommend implementing measures to increase the availability of racially diverse sperm donors, ensuring that third-party reproduction methods like IVF and ICSI are accessible and equitable for individuals of all backgrounds. Addressing these disparities is crucial to providing inclusive reproductive options for all racial and ethnic communities.
Reference
Hobbs CL, Gadson AK, Sadikman S, et al. Desperate for donors: an investigation of the racial and ethnic disparities among donor sperm banks in the US. Poster presented at: ASRM Scientific Congress & Expo 2023; October 14-18, 2023; New Orleans, LA.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More